What is the main business of Medan Invest?

The main business activity of Medan Invest focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 8, 2021.

Where is the headquarters located?

The headquarters is located at: Wędkarska 22D, 10-180 Olsztyn.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $1,503 in 2024, which is a decrease of 98.8% compared to 2023.

No, in 2024 the company was not profitable, reporting a net loss of $5,610. For comparison, in 2023 the loss was $6,059, meaning the company reduced its loss by 12.1%.

What is the main operating cost?

The largest operating cost category falls under materials and energy. This category amounted to $3,910 in 2024, representing 55% of all operating expenses.

Medan Investsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2021-02-08

Share capital

5,000.00 PLN

Registered address

Wędkarska 22D, 10-180 Olsztyn, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 4 financial statements were filed late (the longest delay 105 days for 2021).

2025not filed
202404/09/2025
202304/04/2024
202206/07/2023
202128/10/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 1.50kMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -5.61kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 7.11kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 52.71kMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Dorota Ankiewicz – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Dorota Ankiewiczage 56	91	$1,229.07	91%
Others	9	$121.56	9%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-02-16.

ING Bank Śląski
46 1050 1764 1000 0090 3241 0889
ING Bank Śląski
69 1050 1764 1000 0090 3241 0863
ING Bank Śląski
47 1050 1764 1000 0090 3241 0871

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
OwlieS.A.	$17,199,251.89	owlie.pl
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Vetarissp. z o.o.	$4,335.41	vetaris.pl
BIATsp. z o.o.	$2,327.20	biat.pl
Move-Xsp. z o.o.	$346.78	move-x.eu
HA Technologiessp. z o.o.	$206.67	amalian.pl
Orthoguardsp. z o.o.	$20.64	orthoguard.pl
Optimedussp. z o.o.	$1.00	optimedus.pl
Agri Starsp. z o.o.	$0.29	maskforyou.pl
Novaovasp. z o.o.	$0.16	novaova.pl

Change history

Date	Event
2025-11-01	Business suspended
2022-03-19	Business resumed
2022-01-18	Business suspended
2021-02-25	PKD change (Added: 46.46.Z)
2021-02-08	Entered in the register

FAQ

Last updated: 2026-04-24